COVID-19 Vaccine Prevents Against Reinfection
Findings show protection for all variant periods
FDA Food Safety Program Needs a Revamp: Panel
Program needs an overhaul with greater attention paid to strong leadership and a more proactive culture
Paxlovid Soon Will Not Be Free for Americans
At this point, about 6 million Americans have taken free Paxlovid doses
SGLT-2i Use Before COVID-19 May Reduce Adverse Outcomes in Diabetes Patients
SGLT-2is associated with lowest probability for adverse outcomes followed by glucagon-like peptide-1 receptor agonists, metformin
United States to End Mpox Public Health Emergency in January
More than 29,000 Americans contracted the virus and 17 died during an outbreak that started earlier this year
Dynamically Updating Models Can Improve Prediction of COVID-19 Survival
Drift in model calibration performance was detected immediately, with minor fluctuations in discrimination
HIV Care Services Resilient During COVID-19 Pandemic
Decrease seen in HIV tests performed, persons prescribed PrEP, HIV diagnoses in quarter 2 of 2020, but partial rebound observed in Q3
41.6 Percent of Adults Have Serology Indicative of Past COVID-19 Infection
25.5 percent of those whose serology indicated past infection reported not having been vaccinated, with higher rates seen in young, Black adults
Feds Urge Vaccination as ‘Tripledemic’ Hits More Americans
Vaccination will be key to keeping patients healthy through the winter holidays
Pfizer Asks FDA to Approve Tweaked COVID-19 Booster as Third Shot for Under 5s
Though children aged 5 years and older and adults need only two doses to complete a primary series, younger children need three doses
